Seite auswählen

Fresenius Medical Care are looking to convince Rhön shareholders with another bid for Rhön-Kliniken. This time, the bid would be for 50% and 1 share, a significant change from the initial 90% proposal, which would secure Fresenius only a simple majority. This would leave Fresenius without extensive control possibilities. The price per share will remain equal to EUR 22.50.

The bid made by the Fresenius Board is still subject to approval, however insiders are sceptical about the chances for success of a second bid. 

[ilink url=““] Link zur Quelle ([/ilink]